Literature review and clinical observation of acquired idiopathic hemophilia with a new missense mutation in the factor VIII gene (His2026Arg)
- 作者: ERSHOV V1, GADAEV I1, BUDANOVA D1, PERINA F2, SURIN V1, SALOMASHKINA V1, PSHENICHNIKOVA O1, ZOZULYA N1
-
隶属关系:
- Moscow, Russia
- State Budgetary Institution of Healthcare of Sverdlovsk region “Sverdlovsk Regional Clinical Hospital №1”
- 期: 卷 90, 编号 7 (2018)
- 页面: 118-122
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32817
- DOI: https://doi.org/10.26442/terarkh2018907118-122
- ID: 32817
如何引用文章
全文:
详细
作者简介
V ERSHOV
Moscow, Russiaпроф. каф. госпитальной терапии №1 Москва, Россия
I GADAEV
Moscow, Russiaдоцент каф. госпитальной терапии №1 Москва, Россия
D BUDANOVA
Moscow, Russiaврач-гематолог УКБ №1, отд-ния гематологии клиники госпитальной терапии им. А.А. Остроумова, ORCID iD 0000-0001-6324-2371 Москва, Россия
F PERINA
State Budgetary Institution of Healthcare of Sverdlovsk region “Sverdlovsk Regional Clinical Hospital №1”врач-гематолог высшей квалификационной категории ГБУЗ СО СОКб №1 Ekaterinburg, Russia
V SURIN
Moscow, Russia
Email: vadsurin@mail.ru
с.н.с. Москва, Россия
V SALOMASHKINA
Moscow, Russiaн.с. Москва, Россия
O PSHENICHNIKOVA
Moscow, RussiaМосква, Россия
N ZOZULYA
Moscow, Russiaд.м.н., врач-гематолог, зав. научно-консультативным отделом коагулопатий Москва, Россия
参考
- Kruse-Jarres R, Kempton C.L, Baudo F, Collins P.W, Knoebl P, Leissinger C.A, Tiede A, Kessler C.M. Acquired hemophilia A: Updated review of evidence and treatment guidance. American Journal of Hematology. 2017; 92(7):695-705. https://doi.org/10.1002/ajh.24777
- Cnoebl P, Marco P, Baudo F, Collins P Huth-Kühne A, Nemes L, Pellegrini F, Tengborn L, Lévesque H; EACH2 Registry Contributors. Demographic and clinical data in acquired hemophilia A: results from the European Asquired Hemophilia Registry (EACH2). Journal of Thrombosis and Hemostasis. 2012; 10:622-631. https://doi.org/10.1111/ j.1538-7836.2012.04654.x
- Гатияров Ю.Ф., Цыбиков Н.Н. Аутоантитела к факторам свертывания крови. Сибирский медицинский журнал. 2011; 103(4).
- Bitting R.L, Bent S, Li Y, Kohlwes J. The prognosis and treatment of acquired hemophilia: a systematic review and meta - analysis. Blood Coagulation and Fibrinolysis. 2009; 20(7):517-523. https://doi.org/10. 1097/MBC.0b013e32832ca388
- Kessler C.M, Ma A.D, Al-Mondhiry H.A, Gut R.Z, Cooper D.L. Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry. Blood Coagulation and Fibrinolysis. 2016; 27(7):761-769. https://doi.org/10. 1097/MBC.0000000000000582
- Di Michele D.M. Immune tolerance induction in haemophilia: evidence and the way forward. Journal of Thrombosis and Haemostasis. 2011; 9(s1):216-225. https://doi.org/10.1111/j.1538-7836.2011.04349.x
- Shepherd A.J, Skelton S, Sansom C.E, Gomez K, Moss D.S, Hart D.P. A large - scale computational study of inhibitor risk in non - severe haemophilia A. British journal of haematology. 2015;168(3):413-420. https://doi.org/10.1111/bjh.13131
- Gilles J.G, Saint-Remy J-M. Coagulation factor autoantibodies. In: Shoenfeld Y, Meroni P.L, Gershwin M.E, eds. Autoantibodies. 2nd ed. Amsterdam: Elsevier; 2007:495-510.
- Hofbauer C.J, Whelan S.F, Hirschler M, Allacher P, Horling F.M, Lawo J.P, Oldenburg J, Tiede A, Male C, Windyga J, Greinacher A, Knöbl P.N, Schrenk G, Koehn J, Scheiflinger F, Reipert B.M. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans. Blood. 2015;125(7):1180-1188. https://doi.org/10.1182/blood-2014-09-598268
- Bagnall R.D, Giannelli F, Green P.M. Int22h - related inversions causing hemophilia A: a novel insight into their origin and a new more discriminant PCR test for their detection. Journal of Thrombosis and Haemostasis. 2006; 4(3):591-598. https://doi.org/10.1111/j.1538-7836.2006.01840.x
- Bagnall R.D, Waseem N, Green P.M, Giannelli F. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood. 2002; 99(1):168-174.
- Gouw S.C, van den Berg H.M, Oldenburg J, Astermark J, de Groot P.G, Margaglione M, Thompson A.R, van Heerde W, Boekhorst J, Miller C.H, le Cessie S, van der Bom J.G. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta - analysis. Blood. 2012; 119(12):2922-2934. https://doi.org/ 10.1182/blood-2011-09-379453
- Tiede A, Eisert R, Czwalinna A, Miesbach W, Scharrer I, Ganser A. Acquired haemophilia caused by non - haemophilic factor VIII gene variants. Annals of Hematology. 2010; 89(6):607-612. https://doi.org/ 10.1007/s00277-009-0887-3
- Hwang S.H, Lim J.A, Kim H.C, Lee H.W, Kim H.S. Identification of a shared F8 mutation in the Korean patients with acquired hemophilia A. The Korean Journal of Hematology. 2011; 46(1):49-51. https://dx.doi. org/10.5045%2Fkjh.2011.46.1.49
- Higuchi M, Kazazian H.H.Jr, Kasch L, Warren T.C, Mc Ginniss M.J, Phillips J.A.III, Kasper C, Janco R, Antonarakis S.E. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proceedings of the National Academy of Sciences. 1991; 88(16):7405-7409. https://doi.org/10.1073/pnas.88.16.7405
- Favier R, Lavergne J.M, Costa J.M, Caron C, Mazurier C, Viémont M, Delpech M, Valleix S. Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female. Blood. 2000; 96(13):4373-4375.
- Renault N.K, Dyack S, Dobson M.J, Costa T, Lam W.L, Greer W.L. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. European Journal of Human Genetics. 2007; 15(6):628-637. https://doi.org/10.1038/sj.ejhg.5201799
- Di Michele D.M, Gibb C, Lefkowitz J.M, Ni Q, Gerber L.M, Ganguly A. Severe and moderate haemophilia A and B in US females. Haemophilia. 2014; 20(2):e136-143. https://doi.org/10.1111/hae.12364
- Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine M.D, Friboulet A, Christophe O, Nagaraja V, Kaveri S.V. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII. The Journal of Immunology. 2006;177(2):1355-1363. https://doi.org/10.4049/jimmunol. 177.2.1355
- Wootla B, Dasgupta S, Dimitrov J.D, Bayry J, Lévesque H, Borg J.Y, Borel-Derlon A, Rao D.N, Friboulet A, Kaveri S.V, Lacroix-Desmazes S. Factor VIII hydrolysis mediated by anti - factor VIII autoantibodies in acquired hemophilia. The Journal of Immunology. 2008;180(11):7714-7720. https://doi.org/10.4049/jimmunol.180.11.7714
- Mahendra A, Padiolleau-Lefevre S, Kaveri S.V, Lacroix-Desmazes S. Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A? British journal of haematology. 2012;156(1):3-12. https://doi.org/10.1111/j.1365-2141.2011.08890.x
- Astermark J. FVIII inhibitors: pathogenesis and avoidance. Blood. 2015;125(13):2045-2051. https://doi.org/10.1182/blood-2014-08-5353 28
- Sakurai Y, Takeda T. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder. Journal of Immunology Research. 2014; 2014:1-10. http://dx.doi.org/10.1155/2014/320674
- Takeda T, Sakurai Y, Tatsumi K, Kato J, Kasuda S, Yoshioka A, Shima M. Elevation of B cell - activating factor belonging to the tumour necrosis family family (BAFF) in haemophilia A patient with inhibitor. Thrombosis and haemostasis. 2009; 101(2):408-410. https://doi.org/ 10.1160/TH08-08-0543
- Stoilova-Mc Phie S, Lynch G.C, Ludtke S, Pettitt B.M. Domain organization of membrane - bound factor VIII. Biopolymers. 2013; 99(7):448-459. https://doi.org/10.1002/bip.22199
- Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M, Gilleland D.G. Nonrandom X-inactivation patterns in normal females: lionization ratios vary with age. Blood. 1996; 88(1):59-65.
- Allen R.C, Zoghbi H.Y, Moseley A.B, Rosenblatt H.M, Belmont J.W. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen - receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics. 1992; 51(6):1229-1239.
- Collins P.W, Hirsch S, Baglin T, Dolan G, Hanley J, Makris M, Keeling D.M, Liesner R, Brown S.A, Hay C.R.M. UK Haemophilia Centre Doctors' Organisation. Acquired haemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organistaion. Blood. 2007; 109(5):1870-1877. https://doi.org/10.1182/blood-2006-06-029850
- Franchini M. Rituximab in the treatment of adult acquired haemophilia A: a systematic review. Clinical reviews in Oncology/Hematology. 2007; 63(1):47-52. https://doi.org/10.1016/j.critrevonc.2006.11.004
- Lee Y.S, Ng H.J. Mycophenolate in the remission induction of a patient with acquired haemophilia A. Haemophilia. 2010;16(1):179-189. https://doi.org/10.1111/j.1365-2516.2009.02107.x